Results 11 to 20 of about 109,334 (165)

Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland.

open access: yesPLoS Medicine, 2022
BackgroundVaccination is the most effective means of preventing the spread of infectious diseases. Despite the proven benefits of vaccination, vaccine hesitancy keeps many people from getting vaccinated.Methods and findingsWe conducted a large-scale ...
Lauri Sääksvuori   +5 more
doaj   +1 more source

High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012–2019

open access: yesPreventive Medicine Reports, 2023
Background: Close monitoring of vaccination coverage is important for cervical cancer prevention efforts. The study aims to describe the HPV vaccination coverage by dose in girls eligible for HPV vaccination within Sweden’s childhood immunization program
Jiangrong Wang   +6 more
doaj   +1 more source

Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.

open access: yesPLoS ONE, 2021
In 2015, the World Health Organization substantially revised its guidance for vaccination coverage cluster surveys (revisions were finalized in 2018) and has since developed a set of accompanying resources, including definitions for standardized coverage
John Ndegwa Wagai   +9 more
doaj   +1 more source

Development of Dog Vaccination Strategies to Maintain Herd Immunity against Rabies

open access: yesViruses, 2022
Human rabies can be prevented through mass dog vaccination campaigns; however, in rabies endemic countries, pulsed central point campaigns do not always achieve the recommended coverage of 70%.
Ahmed Lugelo   +8 more
doaj   +1 more source

Financial Interventions to Increase Vaccine Coverage [PDF]

open access: yesPediatrics, 2020
BACKGROUND: Recent vaccine mandates in Australia, as in other high income settings, have sought to change the behavior of parents, including those who would otherwise access nonmedical exemptions.
Katie, Attwell   +4 more
openaire   +2 more sources

Vaccination coverage, delay and loss to follow-up of the triple viral vaccine, in live births between 2017 and 2018 in Brazilian cities [PDF]

open access: yesEpidemiologia e Serviços de Saúde
Objective To estimate measles-mumps-rubella vaccination coverage, delay and loss to follow-up in children up to 24 months old living in Brazilian cities.
Tatiana Lang D’Agostini   +37 more
doaj   +1 more source

Vaccination coverage and reasons for non-vaccination in a district of Istanbul [PDF]

open access: yesBMC Public Health, 2006
Abstract Background In order to control and eliminate the vaccine preventable diseases it is important to know the vaccination coverage and reasons for non-vaccination. The primary objective of this study was to determine the complete vaccination rate; the reasons for non-vaccination and the predictors that influence ...
Bakırcı Nadi, Torun Sebahat D
openaire   +4 more sources

Sustained Increase in Very Low Influenza Vaccination Coverage in Residents and Healthcare Workers of Long-Term Care Facilities in Austria after Educational Interventions

open access: yesVaccines, 2023
Residents of long-term care facilities (LTCFs) are particularly at risk for influenza infections. We aimed to improve influenza vaccination coverage among residents and healthcare workers (HCWs) in four LTCFs by implementing educational programs and ...
Johannes Boyer   +7 more
doaj   +1 more source

Age-appropriate vaccination coverage and its determinants for the polio containing vaccine 1-3 and measles-containing vaccine doses in Zhejiang province, China: A community-based cross-sectional study

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Background: This study aimed to evaluate the age-appropriate coverage and its associated risk factors for the primary vaccination of Polio containing vaccine (PCV) and measles-containing vaccine (MCV) through the secondary use of the 2018 Zhejiang ...
Yu Hu   +4 more
doaj   +1 more source

Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010. [PDF]

open access: yesPLoS ONE, 2012
MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African "meningitis belt". In Niger, the first two phases of the MenAfriVac introduction campaign were conducted targeting 3,135,942 individuals aged 1 to ...
Sung Hye Kim   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy